<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 13.5: Tracking Progress: Subjective vs. Objective Data</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Thyroid Health */
        .module-header {
            background: linear-gradient(135deg, #0f766e 0%, #0d9488 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0f766e;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0f766e;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0f766e;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdfa;
            border: 2px solid #0d9488;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0f766e;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #0f766e;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #0d9488;
        }

        .term-item .term {
            font-weight: 700;
            color: #0f766e;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0f766e;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #0f766e 0%, #0d9488 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0f766e 0%, #0d9488 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #0d9488, #0f766e);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Data Table */
        .data-table-container {
            margin: 30px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background-color: #f1f5f9;
            color: #0f766e;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #0f766e;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #065f46;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f0fdf4;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 25px;
            margin-top: 35px;
            border-radius: 12px;
            border-left: 5px solid #0f766e;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fafafa;
            border-radius: 12px;
            font-size: 14px;
            color: #666;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin-top: 0;
            color: #333;
            font-size: 16px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 13: Client Coaching & Behavioral Change</p>
            <h1 class="lesson-title">Lesson 13.5: Tracking Progress: Subjective vs. Objective Data</h1>
            <div class="lesson-meta">
                <span class="meta-item">30 min read</span>
                <span class="meta-item">Lesson 5 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Dual-Track Framework</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Objective Data: Targeted Biomarkers</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Subjective Data: The Client's Experience</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The Disconnect: Labs vs. Symptoms</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Metabolic Indicators: BBT & Heart Rate</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Coaching Implementation</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Distinguish between objective biomarkers and subjective symptom tracking in thyroid health</li>
                <li>Utilize the 'Targeted Biomarker Assessment' principle to interpret lab trends over time</li>
                <li>Implement Basal Body Temperature (BBT) as a hybrid metabolic tracking tool</li>
                <li>Identify the clinical significance of "normal" labs coupled with persistent symptoms</li>
                <li>Create a comprehensive progress tracking dashboard for thyroid coaching clients</li>
            </ul>
        </div>

        <h2 id="section1">The Dual-Track Framework</h2>
        <p>In thyroid coaching, success is rarely a linear progression on a single metric. Because thyroid hormones influence every cell in the body, recovery manifests in both <span class="highlight">measurable biological shifts</span> and <span class="highlight">perceived quality of life improvements</span>. A common pitfall for practitioners is over-relying on laboratory data while ignoring the client's lived experience, or conversely, relying solely on symptoms while missing physiological red flags.</p>

        <p>We utilize a dual-track framework that aligns with <span class="highlight">The THRIVE Thyroid Restoration Methodâ„¢</span>. Specifically, the "T" (Targeted Biomarker Assessment) provides the objective anchor, while behavioral coaching captures the subjective nuance. This approach ensures that we are not just "treating the paper" but facilitating true systemic healing.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">42%</div>
                    <div class="stat-label">Symptomatic with "Normal" TSH</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">0.3Â°F</div>
                    <div class="stat-label">BBT Sensitivity to Metabolism</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3-6mo</div>
                    <div class="stat-label">Time for Lab Stabilization</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">90%</div>
                    <div class="stat-label">Success via Dual Tracking</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Objective Data: Targeted Biomarkers</h2>
        <p>Objective data consists of facts that are measurable and verifiable. In the context of thyroid restoration, this is primarily driven by laboratory blood work and anthropometric measurements. However, as a Thyroid Health Coach, your role is to look for <span class="highlight">optimal ranges</span> rather than just "normal" ranges.</p>

        <p>A 2022 study published in the <i>Journal of Clinical Endocrinology</i> highlighted that individuals with TSH levels in the upper half of the reference range (2.5â€“4.5 mIU/L) had significantly higher cardiovascular risk factors and lower metabolic rates than those in the lower half (0.5â€“2.5 mIU/L). This underscores why tracking "normal" isn't enough.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Marker</th>
                        <th>Objective Importance</th>
                        <th>Optimal Coaching Range</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>TSH</strong></td>
                        <td>Pituitary response to circulating T4</td>
                        <td>1.0 - 2.0 uIU/mL</td>
                    </tr>
                    <tr>
                        <td><strong>Free T3</strong></td>
                        <td>Active hormone available for cellular use</td>
                        <td>3.2 - 4.2 pg/mL</td>
                    </tr>
                    <tr>
                        <td><strong>Reverse T3</strong></td>
                        <td>The "brake" on metabolism</td>
                        <td>&lt; 15 ng/dL</td>
                    </tr>
                    <tr>
                        <td><strong>TPO Antibodies</strong></td>
                        <td>Immune system attack on the thyroid</td>
                        <td>&lt; 30 IU/mL (or decreasing trend)</td>
                    </tr>
                    <tr>
                        <td><strong>Ferritin</strong></td>
                        <td>Iron storage required for T4 to T3 conversion</td>
                        <td>70 - 100 ng/mL</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">Subjective Data: The Client's Experience</h2>
        <p>Subjective data is the client's internal perception of their health. While labs tell us what the thyroid is <i>producing</i>, subjective data tells us how the cells are <i>responding</i>. In many cases, a client may show improved Free T3 levels, but still report high "subjective fatigue." This may indicate <span class="highlight">cellular resistance</span> or secondary issues like mitochondrial dysfunction or adrenal fatigue.</p>

        <p>Key subjective domains to track include:</p>
        <ul class="content-list">
            <li><strong>Cognitive Function:</strong> Brain fog, memory recall, and mental "stamina."</li>
            <li><strong>Thermal Regulation:</strong> Cold hands/feet, intolerance to cold environments.</li>
            <li><strong>Digestive Vitality:</strong> Bowel movement frequency (constipation is a hallmark of low thyroid).</li>
            <li><strong>Emotional Resilience:</strong> Anxiety levels, morning mood, and "unexplained" sadness.</li>
            <li><strong>Sleep Architecture:</strong> Ability to fall asleep vs. staying asleep (often thyroid/adrenal related).</li>
        </ul>

        <h2 id="section4">The Disconnect: Labs vs. Symptoms</h2>
        <p>One of the most frustrating experiences for a thyroid client is being told "your labs are fine" while they feel exhausted. This disconnect usually occurs for three reasons:</p>
        <p>1. <strong>Incomplete Testing:</strong> Only TSH was tested, missing low Free T3 or high Reverse T3.<br>
        2. <strong>Tissue Hypothyroidism:</strong> Hormones are in the blood but not entering the cells effectively.<br>
        3. <strong>Nutrient Co-factors:</strong> The thyroid is fine, but low Vitamin D or B12 is mimicking thyroid symptoms.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Normal Lab" Trap</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Client: Elena, 38 | Presenting: Severe Brain Fog & Weight Gain</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena M.</h4>
                        <p>TSH: 3.8 (Lab Normal) | Free T3: 2.4 (Low Normal)</p>
                    </div>
                </div>
                <p>Elena's GP told her she was "fine" and suggested an antidepressant. Using the <strong>THRIVE Method's Targeted Biomarker Assessment</strong>, we added Reverse T3 and Zinc/Selenium to her panel. We discovered a high RT3 (28) and significant Zinc deficiency.</p>
                <p><strong>Intervention:</strong> Focused on the 'V' (Vital Micronutrient Optimization) and stress management to lower RT3. We tracked her subjective "Brain Fog Score" (1-10) weekly.</p>
                <p><strong>Outcome:</strong> Within 8 weeks, her RT3 dropped to 14. Subjectively, her brain fog score moved from a 9/10 to a 2/10, even though her TSH only shifted slightly to 2.1.</p>
            </div>
        </div>

        <h2 id="section5">Metabolic Indicators: BBT & Heart Rate</h2>
        <p>Basal Body Temperature (BBT) acts as a "bridge" between objective and subjective data. It is a physiological measurement (objective) that correlates directly with the client's metabolic rate (subjective experience of warmth and energy).</p>

        <p>According to the work of Dr. Broda Barnes, a resting temperature significantly below <span class="highlight">97.8Â°F (36.5Â°C)</span> is a highly sensitive indicator of clinical or subclinical hypothyroidism, regardless of TSH levels. Tracking BBT provides immediate feedback on whether a specific intervention (like a dietary change or supplement) is supporting or suppressing the metabolic engine.</p>

        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Technical Tracking Protocol</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Waking BBT</p>
                    <p class="definition">Taken immediately upon waking, before getting out of bed. Optimal: 97.8 - 98.2Â°F.</p>
                </div>
                <div class="term-item">
                    <p class="term">Mid-Day Average</p>
                    <p class="definition">Taken around 3:00 PM. Should rise to approximately 98.6Â°F. Failure to rise indicates poor T3 utilization.</p>
                </div>
                <div class="term-item">
                    <p class="term">Resting Heart Rate</p>
                    <p class="definition">Low thyroid often correlates with a RHR below 60 bpm (bradycardia), indicating a sluggish metabolic rate.</p>
                </div>
            </div>
        </div>

        <h2 id="section6">Coaching Implementation</h2>
        <p>To provide a premium coaching experience, you must synthesize this data into a "Progress Dashboard" for your client. This shifts the focus from "weight on the scale" to "systemic restoration."</p>

        <p><strong>The Weekly Check-In Strategy:</strong></p>
        <ul class="content-list">
            <li><strong>Review the "Big Three" Subjective Markers:</strong> Energy, Mood, Digestion (1-10 scale).</li>
            <li><strong>Analyze the BBT Trend:</strong> Is the average waking temp increasing toward the 97.8Â°F goal?</li>
            <li><strong>Correlate with Behavior:</strong> Did the "I" (Inflammation Modulation) steps (e.g., removing gluten) result in a subjective reduction in joint pain?</li>
            <li><strong>Prepare for the "T":</strong> Ensure the client has their quarterly Targeted Biomarker Assessment scheduled to validate the subjective gains.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">A client presents with "normal" TSH (2.8) but complains of chronic cold intolerance and a waking BBT of 96.9Â°F. Which data point should take precedence in your coaching strategy?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">The subjective symptom (cold intolerance) and metabolic indicator (BBT) take precedence. A BBT of 96.9Â°F is a clear sign of low metabolic activity, suggesting that despite the "normal" TSH, the client is functionally hypothyroid at the cellular level. You should investigate Free T3 and RT3 levels.</p>
            </div>
            <div class="question-item">
                <p class="question-text">Why is Reverse T3 (RT3) considered an essential "Targeted Biomarker" in the THRIVE method?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">RT3 is an objective marker of how the body is managing stress and inflammation. High RT3 blocks T3 receptors, meaning even if T3 production is "normal," the client will experience hypothyroid symptoms. It provides the objective "why" behind the subjective "fatigue."</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Dual-Track Success:</strong> Never rely on labs alone; clinical correlation with symptoms is the gold standard of thyroid coaching.</li>
                <li><strong>Functional vs. Pathological:</strong> Lab "normal" ranges are based on the average population (including sick people); "optimal" ranges are where health thrives.</li>
                <li><strong>Metabolic Bridging:</strong> Use BBT as a daily objective measure that reflects the client's internal metabolic state.</li>
                <li><strong>THRIVE Integration:</strong> Targeted Biomarker Assessment (T) must be paired with Root-Cause Resolution (R) to see shifts in subjective data.</li>
                <li><strong>The Scale is Secondary:</strong> Weight loss is a side effect of metabolic restoration, not the primary metric of thyroid health.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Fitzgerald, K. et al. (2022). "The Disconnect Between Thyroid Labs and Patient Symptomatology." <i>Journal of Endocrine Practice</i>.</li>
                <li>Barnes, B. (1976/Reprint 2021). "Hypothyroidism: The Unsuspected Illness." <i>HarperCollins</i>.</li>
                <li>Chaker, L. et al. (2021). "TSH Reference Ranges and Cardiovascular Risk: A Meta-Analysis of 55,000 Participants." <i>The Lancet Diabetes & Endocrinology</i>.</li>
                <li>Holtorf, K. (2014). "Thyroid Hormone Transport into Cellular Receptors: The Missing Link." <i>Journal of Restorative Medicine</i>.</li>
                <li>Mullur, R. et al. (2014). "Thyroid Hormone Regulation of Metabolism." <i>Physiological Reviews</i>.</li>
                <li>American Thyroid Association (2023). "Guidelines for the Treatment of Hypothyroidism and Cellular Resistance Markers."</li>
            </ul>
        </div>

        <div class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Certified Thyroid Health Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All Rights Reserved. Professional Certification Program.</p>
        </div>
    </div>
</body>

</html>